Timber Hill’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-12,667
Closed -$42K 3331
2013
Q3
$42K Sell
12,667
-1,406
-10% -$3.71K ﹤0.01% 3147
2013
Q2
$35K Buy
+14,073
New +$33.8K ﹤0.01% 3167

Other funds holding HZNP

Timber Hill's HZNP Position: Q4 2013 in Review

Timber Hill sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2013, closing a stake of 12,667 shares — an estimated $42K sold.

Timber Hill first reported a position in HZNP in Q2 2013 and held it in 2 quarters. The position peaked at $42K in Q3 2013. 95 funds tracked by Wall St. Rank hold HZNP as of Q4 2013.

  • Timber Hill reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2013 after selling out during the quarter.
  • Timber Hill sold 12,667 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2013, an estimated $42K.
  • Timber Hill first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 2 quarters.
  • Timber Hill's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $42K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2013.

Based on Timber Hill's 13F filing for Q4 2013, filed 14 Feb 2014.